A comprehensive view of Branded Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Eli Lilly and Company Applies for Patent on Chronic Nightly Dosing of Lasmiditan for Migraine Prevention
Published:
May 08, 2024
by Pharmaceutical Patent News
|
Regeneron Pharma Submits Patent Application for Treatment of Varicose Veins with PIEZO Type Mechanosensitive Ion Channel Component 1 (PIEZO1) Agonists
Published:
May 08, 2024
by Pharmaceutical Patent News
|
Patent Issued for Anti-VEGF protein compositions and methods for producing the same (USPTO 11958894)
Published:
May 07, 2024
by Angiogenesis Daily
|
TAR-210 results show 90% recurrence-free survival and 90% complete response in patients with high-risk and intermediate-risk non–muscle-invasive bladder cancer, respectively
Published:
May 05, 2024
by Janssen Pharmaceutical Companies
|
Patent Issued for Pharmaceutical composition (USPTO 11951103)
Published:
April 30, 2024
by Angiogenesis Daily
|
Ask us about our R&D/Patents market view